(no text — see the shared post below)
When someone has a heart attack, they are immediately put on 80mg of Atorvastatin after they are stabilized.
This has been the standard of care for many years now.
Do you know why?
Amazingly, studies have shown a big reduction in post heart attack mortality in just 14 days by doing this!
The PROVE IT-TIMI 22 Trial demonstrated an almost 30% decrease in risk of dying, repeat heart attack, or rehospitalization, in just 30 days when patients were placed on 80mg Atorvastatin immediately after having a heart attack, as compared to a lower potency statin.
The fact that the high dose statin worked this fast likely has little to do with lowering LDL per se. Instead it is thought to be the pleiotropic effects of statins, e.g. the anti-inflammatory effect and the stabilizing effects on plaque and the endothelium, which is responsible for this fast mortality reduction after a heart attack. Statins do far more than just lower LDL, particularly the lipophilic ones like Atorvastatin.
If you ever have a heart attack, do not fight with the hospital staff when they immediately put you on 80mg Atorvastatin. It may save your life in the next few weeks. (Save any fights until after you are out of immediate danger.)
The journal paper where this trial result (PROVE IT-TIMI 22) was first reported is linked to below:
PaperScienceDirect articlesciencedirect.com
Note:
Some have argued that the pleiotropic effects of statins are due, at least in part, to the lower LDL. For example, the LDL itself is intrinsically inflammatory. It attracts immune cells, e.g. once it gets inside the arterial wall and oxidizes. So lowering LDL can itself lower arterial inflammation.
Quoting from the paper:
“The composite end point at 30 days [death, MI, rehospitalization] occurred in 3.0% of patients receiving atorvastatin 80 mg versus 4.2% of patients receiving pravastatin 40 mg (hazard ratio [HR] = 0.72; 95% confidence interval [CI], 0.52 to 0.99; p = 0.046). In stable patients, atorvastatin 80 mg was associated with a composite event rate of 9.6% versus 13.1% in the pravastatin 40 mg group (HR = 0.72; 95% CI, 0.58 to 0.89; p = 0.003).”
“Intensive statin therapy early after ACS [Acute Coronary Syndromes, e.g. heart attack] leads to a reduction in clinical events at 30 days, consistent with greater early pleiotropic effects.”
#lipitor80HD #statinspleiotropyHD #statinsHD #heartattackHD #inflammationHD #endotheliumHD #plaqueHD